NCT04956861View on ClinicalTrials.gov

HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

December 17, 2015

Primary Completion Date

August 7, 2020

Study Completion Date

August 7, 2020

Conditions
HIV-1
Interventions
BEHAVIORAL

Individualized Targeted Sleep

The investigators will employ an 8-week individualized targeted sleep intervention. Individualized targeted interventions have the advantage of improving adherence, reducing attrition, and making the strategy personally meaningful.

Trial Locations (1)

80309

UC-Boulder Clinical and Translational Research Center, Boulder

All Listed Sponsors
lead

University of Colorado, Boulder

OTHER

NCT04956861 - HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction | Biotech Hunter | Biotech Hunter